Long-term efficacy of electroconvulsive therapy combined with different antipsychotic drugs in previously resistant shizophrenia

Psychiatria Danubina

Volumn 21, Issue 2, 2009, Pages 179-186

  Ravanić, Dragan B ^a   Pantović, Mihailo M ^b   Milovanović, Dragan R ^b   Dukić Dejanović, Slavica ^a   Janjić, Vladimir ^a   Ignjatović, Dragana Ristić ^a   Jović, Suzana D ^c   Jurišić, Vladimir ^d   Jevtović, Isidor ^d  

^a CLINICAL CENTRE KRAGUJEVAC   (Serbia)

^b SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^c Colledge of Nursing ^*  (Serbia)

^d Medical Faculty   (Serbia)

Author keywords

Antipsychotics; Combination; ECT; Schizophrenia

Indexed keywords

OLANZAPINE; RISPERIDONE; SULPIRIDE;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYNDROME; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTPATIENT; PATIENT COMPLIANCE; PROSPECTIVE STUDY; PSYCHOMETRY; RATING SCALE; SCHIZOPHRENIA; TREATMENT FAILURE;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SCHIZOPHRENIA; SULPIRIDE; YOUNG ADULT;

EID: 67651235616     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. st edition. London: Chapman and Hall, 1991.
2. Banerjee SB, Rajendran R, Dias BG, Ladiwala U, Tole S & Vaidya VA: Recruitment of the Sonic hedgehog signalling cascade in electroconvulsive seizure-mediated regulation of adult rat hippocampal neurogenesis. Eur J Neurosci 2005; 22:1570-1580. (Pubitemid 41482945)
3. Borowicz KK, Zadrozniak M & Czuczwar SJ: Trans-4-aminocrotonic acid (TACA), a potent agonist of GABA(A) and GABA(C) receptors, shows a proconvulsant action in the electroconvulsive threshold test in mice. Pharmacol Rep 2005; 57:121-123.
4. Braga RJ & Petrides G: The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia. J ECT 2005; 21:75-83. (Pubitemid 40800031)
5. Chanpattana W & Andrade C: ECT for treatment- resistant schizophrenia: a response from the Far East to the UK NICE Report. J ECT 2006; 22:4-12. (Pubitemid 44491123)
6. Chanpattana W & Chakrabhand ML: Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia. Psychiatry Res 2001; 105:107.
7. Chanpattana W, Kojima K, Kramer BA, Intakorn A, Sasaki S & Kitphati R: ECT practice in Japan. J ECT 2005; 21:139-144.
8. Fazio AF: A concurrent validational study of the NCHS General. Well-Being Schedule. Vital Health Stat 2 1977; 73:1-53.
9. First MB, Spitzer RL, Gibbon M & Williams GBW: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Washington, DC: American Psychiatric Press, 1997.
10. Greene YM, McDonald WM, Duggan J & Cooper R: Ventricular ectopy associated with low-dose intravenous haloperidol and electroconvulsive therapy. J ECT 2000; 16:309-311.
11. Guy W: ECDEU Assessment Manual for Psychopharmacology - Revised (DHEW Publ No ADM 76-338). Rockville: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs 1976; 218-222.
12. Hirose S, Ashby CR & Mills MJ: Effectiveness of ECT combined with risperidone against aggression in schizophrenia. J ECT 2001; 17:22-26. (Pubitemid 32246861)
13. Ikeji OC, Ohaeri JU, Osahon RO & Agidee RO: Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria. East Afr Med J 1999; 76: 644-650.
14. Kay SR, Fiszbein A & Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Shizophr Bull 1987; 13:261-276.
15. Kho KH, Blansjaar BA, de Vries S, Babuskova D, Zwinderman AH & Linszen DH: Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia - an open label study. Eur Arch Psychiatry Clin Neurosci 2004; 254:372-379. (Pubitemid 40192992)
16. Lévy-Rueff M, Jurgens A, Lôo H, Olié JP & Amado I: Maintenance electroconvulsive therapy and treatment of refractory schizophrenia. Encephale 2008; 34:526-533.
17. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J & Hsiao JK: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353:1209-1223.
18. Lisanby SH: Electroconvulsive therapy for depression. N Engl J Med 2007; 357:1939-1945.
19. Motohashi N, Awata S & Higuchi T: A questionnaire survey of ECT practice in university hospitals and national hospitals in Japan. J ECT 2004; 20:21-23. (Pubitemid 38480342)
20. Norman RM, Malla AK, McLean T, Voruganti LP, Cortese L, McIntosh E et al: The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr Scand 2000; 102:303-309. (Pubitemid 30749302)
21. Ohaeri JU, Hedo CC, Enyidah SN & Ogunniyi AO: Tissue injury-inducing potential of unmodified ECT: serial measurement of acute phase reactants. Convuls Ther 1992; 8:253-257. (Pubitemid 23039043)
22. Painuly N & Chakrabarti S: Combined use of electroconvulsive therapy and antipsychotics in schizophrenia: the Indian evidence. A review and a meta-analysis. J ECT 2006; 22:59-66. (Pubitemid 44491134)
23. Srzich A & Turbott J: Nonconvulsive generalized status epilepticus following electroconvulsive therapy. Aust N Z J Psychiatry 2000; 34:334-336. (Pubitemid 30206776)
24. Suzuki K, Awata S & Matsuoka H: One-year outcome after response to ECT in middle-aged and elderly patients with intractable catatonic schizophrenia. J ECT 2004; 20:99-106. (Pubitemid 38747571)
25. Tan QR, Wang W, Wang HH, Zhang RG, Guo L & Zhang YH: Treatment of catatonic stupor with combination of modified electroconvulsive treatment and olanzapine: a case report. Clin Neuropharmacol 2006; 29:154-156. (Pubitemid 44503894)
26. Tang WK & Ungvari GS: Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27:373-379. (Pubitemid 36403728)
27. Tharyan P & Adams CE: Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev 2005; 2.CD000076.
28. Timotijević I i Paunović VR: Instrumenti kliničke procene. Beograd: Naučna knjiga, 1992.
29. Ucok A & Cakir S: Electroconvulsive therapy in first-episode schizophrenia. J ECT 2006; 22:38-42.
30. Vangu MD, Esser JD, Boyd IH & Berk M: Effects of electroconvulsive therapy on regional cerebral blood flow measured by 99mtechnetium HMPAO SPECT. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27:15-19. (Pubitemid 36126642)
31. Yoshida K, Higuchi H, Kamata M, Yoshimoto M, Shimizu T & Hishikawa Y: Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22:435-444. (Pubitemid 28126246)